Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenues $ 13,664 $ 10,780 $ 27,136 $ 20,408
Cost of revenues 7,209 5,715 14,340 10,957
Gross profit 6,455 5,065 12,796 9,451
Operating expenses:        
General and administrative 7,013 4,760 12,360 8,967
Sales and marketing 3,749 2,649 7,313 5,212
Research and development 4,418 2,590 8,250 5,300
Total operating expenses 15,180 9,999 27,923 19,479
Loss from operations (8,725) (4,934) (15,127) (10,028)
Other income (expense):        
Interest expense (639) (558) (1,255) (966)
Interest income 410 276 913 438
Change in fair value of warrant liability 0 (69) 0 (69)
Other 590 303 527 437
Total other income (expense), net 361 (48) 185 (160)
Net loss before income taxes (8,364) (4,982) (14,942) (10,188)
Income tax expense 86 51 7 84
Net loss (8,450) (5,033) (14,949) (10,272)
Other comprehensive income (loss):        
Foreign exchange translation adjustment (194) (298) (181) (331)
Total comprehensive loss $ (8,644) $ (5,331) $ (15,130) $ (10,603)
Net loss per share of common stock, basic (in dollars per share) $ (0.16) $ (0.12) $ (0.28) $ (0.25)
Net loss per share of common stock, diluted (in dollars per share) $ (0.16) $ (0.12) $ (0.28) $ (0.25)
Weighted average shares of common stock outstanding, basic (in shares) 53,387,349 43,607,984 53,223,008 40,566,425
Weighted average shares of common stock outstanding, diluted (in shares) 53,387,349 43,607,984 53,223,008 40,566,425